Surescripts CEO Tom Skelton; CVS Health Executive Vice President and CMO Troyen Brennan, MD; and Cigna Chief Clinical Officer Steve Miller, MD, will discuss how to improve patients’ access to prescription drug costs and benefit plans at the conference.
“HIMSS is a chance for the industry to assess progress, engage with other leaders and chart a path forward,” Mr. Skelton said in a news release. “Our focus is on how prescription price transparency and interoperability solutions are achieving value-based care’s goals of improved care for individuals, better population health management and lower costs.”
More articles on pharmacy:
Cancer therapy prices prevent access to treatment, WHO says
Despite controversies, J&J ranks among Fortune’s most-admired companies
Bristol-Myers swings to $1.2B profit in Q4
